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BACKGROUND Although forward stroke volume (FSV) increases after
the successful MitraClip procedure for signiﬁcant mitral regurgitation
patients, the effect of FSV response on their outcomes remains un-
known. In this study, the prognostic impact of FSV response after the
MitraClip procedure was investigated.
METHODS Study population included 160 patients with the successful
MitraClip implantation whom FSV was able to be calculated using
pulse-wave Doppler at baseline and discharge in transthoracic echo-
cardiography. Responder of FSVwas deﬁned as an increase greater than
10% in baseline FSV at discharge. Clinical and echocardiographic out-
comes were compared between responders and nonresponders of FSV.
RESULTS There were 88 responders (42.6  9.7 ml to 59.3  13.5 ml,
p<0.001) and 72 nonresponders (54.0  11.3 ml to 49.2  11.3 ml,
p¼0.001) of FSV after the procedure. In both groups, left ventricular
(LV) end-diastolic volume was reduced and LV end-systolic volume
was not changed at discharge. Further reduction of LV end-diastolic
and end-systolic volumes was observed from discharge to 12-month
follow-up in responders (149.2  43.7 ml to 140.1  45.3 ml, p¼0.003;
80.8  38.3 ml to 75.1  40.9 ml, p¼0.01) but not in nonresponders
(152.8  56.2 ml to 154.1  58.1 ml, p>0.99; 89.9  51.2 ml to 88.4 
54.8 ml, p¼0.48). Although New York Heart Association functional
class improved in both groups, it was signiﬁcantly better in re-
sponders at 12-month (p¼0.048). Among patients with estimated
glomerular ﬁltration rate (eGFR) <60ml/min/1.73m2, signiﬁcant
improvement in eGFR was observed in responders (38.3  13.4 ml/
min/1.73m2 to 43.0  14.6 ml/min/1.73m2, p¼0.02) and not in non-
responders (38.2  13.3 ml/min/1.73m2 to 38.8  18.3 ml/min/1.73m2,
p¼0.76). The median follow-up duration with surviving patients was
1139 days (interquartile range 517 to 1813 days). All-cause mortality at
3-year was signiﬁcantly lower in responders (18.7%) than in non-
responders (39.0%, p¼0.009) (Figure). Multivariate analysis identiﬁed
nonresponders of FSV as an independent predictor of all-cause
mortality (hazard ratio 2.03, 95% conﬁdence intervals 1.05-3.95, p¼0.04).
CONCLUSIONS Responder of FSV after the MitraClip procedure was
associated with more favorable clinical outcomes. The FSV response
could predict the subsequent LV reverse remodeling.
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BACKGROUND Left atrial appendage occlusion (LAAO) may be
considered in patients with non-valvular atrial ﬁbrillation and
contraindication to oral anticoagulation therapy. We aimed to inves-
tigate the procedural safety and long-term outcome of patients un-
dergoing LAAO therapy due to previous intracranial bleeding (ICB).
METHODS Data from the Amplatzer Cardiac Plug multicenter registry
on 1047 consecutive patients were analyzed. Patients with previous
ICB as indication for LAAO were compared to patients with other
indications.
RESULTS A total of 198 patients (18.9%) with previous ICB were
identiﬁed. They were more commonly male (69.7 vs 60.1%, p¼0.012),
with history of previous stroke (63.6 vs 32.7%, p<0.001). The
CHA2DS2-VASc score was similar (4.51.5 vs 4.41.6, p¼0.687). The
HAS-BLED score was higher in patients with previous ICB (3.51.1 vs
3.11.2, p<0.001). The annual stroke risk was similar (5.72.8% vs
5.62.8%, p¼0.480) whereas the annual major bleeding risk was
higher for patients with previous ICB (6.43.9% vs 5.13.7%,
p<0.001). There was a trend towards less peri-procedural major safety
events for patients with previous ICB (2.5 vs 5.4%, p¼0.1). The average
follow-up was 1.3 years. The observed annual stroke/TIA rate (pro-
cedure and follow-up) for patients with previous ICB was 1.4% (4.3%
absolute reduction, 75% relative reduction according to the CHA2DS2-
VASc score) and 2.5% for the rest (3.1% absolute reduction, 55% rela-
tive reduction). The observed annual major bleeding rate (procedure
and follow-up) for patients with previous ICB was 0.7% (5.7% absolute
reduction, 89% relative reduction according to the HAS-BLED score)
and 2.4% for the rest (2.7% absolute reduction, 47% relative
reduction).
CONCLUSIONS Patients with previous ICB as an indication for LAAO
had a signiﬁcant reduction in stroke/TIA and a remarkably low fre-
quency of major bleeding during follow-up.
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BACKGROUND Cardiac computed tomography (CT) imaging of the
mitral annulus plays an integral role in appropriately sizing a trans-
catheter mitral valve implantation (TMVI) device. There are risks of
TMVI including paravalvular regurgitation and left ventricular
outﬂow tract (LVOT) obstruction. To mitigate these risks, measure-
ment of a D-shaped annulus has been proposed and has largely been
performed using cardiac CT. We sought to establish the accuracy of
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measuring the D-shaped annulus as compared to cardiac CT.
METHODS Patients being considered for TMVI with moderate-severe
mitral regurgitation between 2012 and 2014 at St Paul’s Hospital,
Vancouver, B.C. were included in this retrospective study. Patients
who did not have both 3D-TEE and cardiac CT were excluded. Pre-
existing Philips Q-Laboratory mitral valve quantiﬁcation software was
used and our group created a modiﬁed protocol to speciﬁcally mea-
sure the D-shaped annulus. A single observer analyzed all cases and a
second observer analyzed 15 cases for inter-observer variability. A
third observer unfamiliar with the study, followed the protocol and
analyzed 15 cases. The relationship between 3D-TEE and cardiac CT
measured annular dimensions was evaluated using linear regression
analysis Spearmans Rho non-parametric correlation coefﬁcient.
Bland-Altman analysis was performed to assess agreement between
the two imaging modalities. Inter- and intra-observer agreement was
quantiﬁed with intraclass correlation coefﬁcient.
RESULTS Forty-one patients were included in the study: age 77þ14
years; 71% males (n¼29); mitral regurgitation etiology functional in
54% (n¼22) and myxomatous in 46% (n¼19); severe mitral regurgita-
tion in 88% (n¼36). The correlations between cardiac CT and 3D-TEE
mitral annular measurements were as follows: area (r¼0.84,
p<0.0001); circumference (r¼0.82, p<0.0001); TT distance (r¼0.68,
p<0.0001) and SL distance (r¼0.69, p<0.0001). The Bland-Altman
analysis showed good agreement of all parameters with the exception
of circumference: mean bias 3DTEE-CT, area ¼ -0.181.8cm (p¼0.54),
TT distance ¼ 1.13.4mm (p¼0.05), SL distance ¼ 0.673.6mm
(p¼0.23), and circumference ¼ 811mm (p<0.001). There was excel-
lent intra- and inter-observer agreement with intra-class correlation
coefﬁcients > 0.90 for all annular parameters.
CONCLUSIONS This study demonstrates that 3D echocardiographic
assessment of the D-shaped mitral annulus is comparable to cardiac
CT. The use of pre-existing mitral valve quantiﬁcation software with a
standardized protocol allows an observer to provide an accurate
assessment of the D-shaped mitral annulus.
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BACKGROUND Left atrial appendage (LAA) closure device sizing re-
quires accurate pre-procedural measurements. Presently, multi-
modality imaging with trans-esophageal echocardiography (TEE),
computed tomography angiography (CTA) and ﬂuoroscopy can be
utilized for this purpose. Correlation between measurements obtained
by all three modalities has not been adequately assessed.
METHODS Consecutive patients who underwent percutaneous LAA
closure [Amplatzer Cardiac Plug (ACP), Amulet, or WATCHMAN de-
vices] at Vancouver General Hospital who underwent routine CTA
pre-procedure were included in this analysis. Indications for LAA
closure were nonvalvular atrial ﬁbrillation patients at high stroke-risk
and contraindications for oral anticoagulation. Prospective cardiac-
gated CTAs were performed with Toshiba 320-detector or Siemens 2nd
generation 128-slice dual-source scanners, and images were inter-
preted with VitreaWorkstation. GFR <30mL/min/1.73m2 was an
exclusion for CTA. TEE was performed pre-procedure and largest
dimension used. Fluoroscopic measurements were performed with 5F
marker pigtails after transseptal puncture during LAA closure proce-
dure. All procedures were done under general anesthesia and TEE
guidance. LAA dimensions were obtained at (1) ACP landing zone at
10mm within the oriﬁce, (2) WATCHMAN anatomic oriﬁce, and (3)
WATCHMAN depth measurements. These measurements were
compared between CTA, TEE, and ﬂuoroscopy with Pearson (R) cor-
relation. Selection of device size was typically based upon the largest
oriﬁce dimension from any modality.
RESULTS Forty-one patients underwent CTA pre-LAA closure (8 ACP,
9 Amulet, 24 WATCHMAN). Average age was 74.9  8.8yrs, mean
CHADS2 score 2.9  1.3, and CHADS-VASc score 4.6  1.6. All had
contraindications to oral anticoagulation. Procedural success for de-
vice implantation was 100%. For ACP landing zone (deﬁned as 10mm
from LAA oriﬁce), all 3 modalities signiﬁcantly correlated with eachother: R value was 0.70 (p<0.00001) ﬂuoroscopy/TEE, 0.46 (p¼0.005)
ﬂuoroscopy/CTA, and 0.43 (p¼0.011) CTA/TEE. The mean landing
zone measurement was largest with CTA (23.6  4.2mm), followed by
TEE (21.9  5.3mm), and smallest with ﬂuoroscopy (19.8  5.3mm).
CONCLUSIONS All thee imaging modalities correlated with oriﬁce
landing zone measurements. CTA provided the largest measurements,
followed by TEE and ﬂuoroscopy.
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BACKGROUND Left atrial appendage (LAA) occlusion is gaining
increasing importance in clinical practice worldwide after having been
approved by the FDA as alternative to warfarin. Especially for the
Watchman device (Boston Scientiﬁc, Marlborough, MA, USA), the
measurement of the ostium size is a crucial step during implantation
and in many cases challenging, especially in ovally shaped ostia.
Choosing the wrong device size might lead to LAA perforations or
incomplete occlusions. Currently, ostium size is assessed by angiog-
raphy and transesophageal echocardiography (TEE, 0, 45, 90, 135).
We assessed whether the perimeter derived diameter (PDD) and area
derived diameter (ADD) as assessed by intraprocedural 3D TEE help to
standardize the process of choosing the device size even in ovally
shaped ostia.
METHODS 55 consecutive patients underwent LAA occlusion with the
Watchman device. The device size was chosen to yield a compres-
sion of 10-30% by angiography and 2D TEE. In addition, 3D TEE data
sets of the LAA ostium were obtained before and after implantation in
order to calculate PDD and ADD.
RESULTS The results for pre-interventional measured area, perim-
eter, PDD and ADD as compared with the pre-deﬁned target range of
10-30% compression are shown in Figure 1. The 3D measurements
correlate well with the calculated values for a 10-30% range of
compression.
CONCLUSIONS Measured PDD and ADD show a good correlation with
the implanted device sizes, especially the PDD correlates well with the
conventional 2D measurements. Therefore, we propose a standard-
ized algorithm for choosing the Watchman device sizes using 3D TEE
images as shown in Table 1, that can be adopted directly to clinical
practice. In comparison to the conventional 2D measurements this
algorithm simpliﬁes the sizing of the ostium and thereby possibly
further improves safety and efﬁcacy of the procedure.
